{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:51:42Z","timestamp":1761519102828},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,9,28]],"date-time":"2014-09-28T00:00:00Z","timestamp":1411862400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s10549-014-3143-z","type":"journal-article","created":{"date-parts":[[2014,9,27]],"date-time":"2014-09-27T08:31:51Z","timestamp":1411806711000},"page":"117-123","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Can mammographic and sonographic imaging features predict the Oncotype DX\u2122 recurrence score in T1 and T2, hormone receptor positive, HER2 negative and axillary lymph node negative breast cancers?"],"prefix":"10.1007","volume":"148","author":[{"given":"Monica Maria","family":"Yepes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ada Pat","family":"Romilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Collado-Mesa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Miguel","family":"Net","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Kiszonas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristopher L.","family":"Arheart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Gl\u00fcck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,28]]},"reference":[{"key":"3143_CR1","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1056\/NEJMoa041588","volume":"351","author":"S Paik","year":"2004","unstructured":"Paik S, Shak S, Tang G et al (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351:2817\u20132826","journal-title":"N Engl J Med"},{"issue":"23","key":"3143_CR2","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1200\/JCO.2005.04.7985","volume":"24","author":"S Paik","year":"2006","unstructured":"Paik S, Tang G, Shak S et al (2006) Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 24(23):3726\u20133734","journal-title":"J Clin Oncol"},{"issue":"8","key":"3143_CR3","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","volume":"22","author":"A Goldhirsch","year":"2011","unstructured":"Goldhirsch A, Wood WC, Coates AS et al (2011) Strategies for subtypes\u2014dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the primary therapy of early breast cancer 2011. Ann Oncol 22(8):1736\u20131747","journal-title":"Ann Oncol"},{"issue":"22","key":"3143_CR4","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1002\/cncr.25269","volume":"116","author":"CM Kelly","year":"2010","unstructured":"Kelly CM, Krishnamurthy S, Bianchini G et al (2010) Utility of Oncotype DX risk estimates in clinically intermediate risk hormone receptor-positive, HER2-normal, grade II, lymph node-negative breast cancers. Cancer 116(22):5161\u20135167","journal-title":"Cancer"},{"key":"3143_CR5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4137\/BIC.S9455","volume":"5","author":"M Kittaneh","year":"2013","unstructured":"Kittaneh M, Montero AJ, Gluck S (2013) Molecular profiling for breast cancer: a comprehensive review. Biomark Cancer 5:61\u201370","journal-title":"Biomark Cancer"},{"issue":"22","key":"3143_CR6","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/jnci\/89.22.1673","volume":"89","author":"B Fisher","year":"1997","unstructured":"Fisher B, Dignam J, Wolmark N et al (1997) Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer. J Natl Cancer Inst 89(22):1673\u20131682","journal-title":"J Natl Cancer Inst"},{"issue":"9855","key":"3143_CR7","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/S0140-6736(12)61611-0","volume":"380","author":"Independent U.K. Panel on Breast Cancer Screening","year":"2012","unstructured":"Independent U.K. Panel on Breast Cancer Screening (2012) The benefits and harms of breast cancer screening: an independent review. Lancet 380(9855):1778\u20131786","journal-title":"Lancet"},{"issue":"1","key":"3143_CR8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.molonc.2010.11.003","volume":"5","author":"A Prat","year":"2011","unstructured":"Prat A, Perou CM (2011) Deconstructing the molecular portraits of breast cancer. Mol Oncol 5(1):5\u201323","journal-title":"Mol Oncol"},{"issue":"8","key":"3143_CR9","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","volume":"27","author":"JS Parker","year":"2009","unstructured":"Parker JS, Mullins M, Cheang MC et al (2009) Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol 27(8):1160\u20131167","journal-title":"J Clin Oncol"},{"issue":"21","key":"3143_CR10","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1206809","volume":"367","author":"A Bleyer","year":"2012","unstructured":"Bleyer A, Welch HG (2012) Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 367(21):1998\u20132005","journal-title":"N Engl J Med"},{"issue":"20","key":"3143_CR11","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/jnci\/djs394","volume":"104","author":"E Amir","year":"2012","unstructured":"Amir E, Bedard PL, Ocana A, Seruga B (2012) Benefits and harms of detecting clinically occult breast cancer. J Natl Cancer Inst 104(20):1542\u20131547","journal-title":"J Natl Cancer Inst"},{"key":"3143_CR12","doi-asserted-by":"crossref","first-page":"f385","DOI":"10.1136\/bmj.f385","volume":"346","author":"M Baum","year":"2013","unstructured":"Baum M (2013) Harms from breast cancer screening outweigh benefits if death caused by treatment is included. BMJ 346:f385","journal-title":"BMJ"},{"issue":"1","key":"3143_CR13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/epirev\/mxr009","volume":"33","author":"R Gelder de","year":"2011","unstructured":"de Gelder R, Heijnsdijk EA, van Ravesteyn NT, Fracheboud J, Draisma G, de Koning HJ (2011) Interpreting overdiagnosis estimates in population-based mammography screening. Epidemiol Rev 33(1):111\u2013121","journal-title":"Epidemiol Rev"},{"issue":"1","key":"3143_CR14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10552-011-9867-8","volume":"23","author":"PC Gotzsche","year":"2012","unstructured":"Gotzsche PC, Jorgensen KJ, Zahl PH, Maehlen J (2012) Why mammography screening has not lived up to expectations from the randomised trials. Cancer Causes Control 23(1):15\u201321","journal-title":"Cancer Causes Control"},{"issue":"1","key":"3143_CR15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1258\/jms.2012.011104","volume":"19","author":"BN Hellquist","year":"2012","unstructured":"Hellquist BN, Duffy SW, Nystrom L, Jonsson H (2012) Overdiagnosis in the population-based service screening programme with mammography for women aged 40 to 49\u00a0years in Sweden. J Med Screen 19(1):14\u201319","journal-title":"J Med Screen"},{"key":"3143_CR16","doi-asserted-by":"crossref","first-page":"b2587","DOI":"10.1136\/bmj.b2587","volume":"339","author":"KJ Jorgensen","year":"2009","unstructured":"Jorgensen KJ, Gotzsche PC (2009) Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ 339:b2587","journal-title":"BMJ"},{"issue":"7","key":"3143_CR17","doi-asserted-by":"crossref","first-page":"491","DOI":"10.7326\/0003-4819-156-7-201204030-00005","volume":"156","author":"M Kalager","year":"2012","unstructured":"Kalager M, Adami HO, Bretthauer M, Tamimi RM (2012) Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Intern Med 156(7):491\u2013499","journal-title":"Ann Intern Med"},{"issue":"4","key":"3143_CR18","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2217\/fon.09.25","volume":"5","author":"D Puliti","year":"2009","unstructured":"Puliti D, Paci E (2009) The other side of technology: risk of overdiagnosis of breast cancer with mammography screening. Future Oncol 5(4):481\u2013491","journal-title":"Future Oncol"},{"key":"3143_CR19","doi-asserted-by":"crossref","first-page":"g366","DOI":"10.1136\/bmj.g366","volume":"348","author":"AB Miller","year":"2014","unstructured":"Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA (2014) Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ 348:g366","journal-title":"BMJ"},{"issue":"13","key":"3143_CR20","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/jama.2014.1398","volume":"311","author":"LE Pace","year":"2014","unstructured":"Pace LE, Keating NL (2014) A systematic assessment of benefits and risks to guide breast cancer screening decisions. JAMA 311(13):1327\u20131335","journal-title":"JAMA"},{"key":"3143_CR21","volume-title":"Breast imaging reporting and data system: ACR BI-RADS mammography","author":"DJ D\u2019Orsi","year":"2003","unstructured":"D\u2019Orsi DJ, Bassett LW, Berg WA (2003) Breast imaging reporting and data system: ACR BI-RADS mammography, 4th edn. American College of Radiology, Reston","edition":"4"},{"key":"3143_CR22","unstructured":"Daye D, Gavenonis S, Keller B, Ashraf A, Mies C, Feldman M, Rosen M, Kontos D (2012) Breast MRI tumor features as predictive markers of breast cancer recurrence. In: Radiological Society of North America 2012 scientific assembly and annual meeting, Nov 25\u201330, Chicago"},{"issue":"9202","key":"3143_CR23","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0140-6736(00)82008-5","volume":"355","author":"L Tabar","year":"2000","unstructured":"Tabar L, Chen HH, Duffy SW et al (2000) A novel method for prediction of long-term outcome of women with T1a, T1b, and 10\u201314\u00a0mm invasive breast cancers: a prospective study. Lancet 355(9202):429\u2013433","journal-title":"Lancet"},{"issue":"6","key":"3143_CR24","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1046\/j.1524-4741.2001.07607.x","volume":"7","author":"PJ Slanetz","year":"2001","unstructured":"Slanetz PJ, Giardino AA, Oyama T et al (2001) Mammographic appearance of ductal carcinoma in situ does not reliably predict histologic subtype. Breast J 7(6):417\u2013421","journal-title":"Breast J"},{"issue":"3","key":"3143_CR25","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2214\/ajr.159.3.1323923","volume":"159","author":"PC Stomper","year":"1992","unstructured":"Stomper PC, Connolly JL (1992) Ductal carcinoma in situ of the breast: correlation between mammographic calcification and tumor subtype. Am J Roentgenol 159(3):483\u2013485","journal-title":"Am J Roentgenol"},{"issue":"1","key":"3143_CR26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1148\/radiology.196.1.7784555","volume":"196","author":"AT Stavros","year":"1995","unstructured":"Stavros AT, Thickman D, Rapp CL, Dennis MA, Parker SH, Sisney GA (1995) Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology 196(1):123\u2013134","journal-title":"Radiology"},{"issue":"4","key":"3143_CR27","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.2214\/AJR.09.2355","volume":"194","author":"BE Dogan","year":"2010","unstructured":"Dogan BE, Gonzalez-Angulo AM, Gilcrease M, Dryden MJ, Yang WT (2010) Multimodality imaging of triple receptor-negative tumors with mammography, ultrasound, and MRI. Am J Roentgenol 194(4):1160\u20131166","journal-title":"Am J Roentgenol"},{"issue":"Suppl 6","key":"3143_CR28","doi-asserted-by":"crossref","first-page":"vi23","DOI":"10.1093\/annonc\/mds191","volume":"23","author":"BE Dogan","year":"2012","unstructured":"Dogan, BE, Turnbull, LW (2012) Imaging of triple-negative breast cancer. Ann Oncol 23(Suppl 6):vi23\u2013vi29","journal-title":"Ann Oncol"},{"issue":"5","key":"3143_CR29","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00330-009-1656-3","volume":"20","author":"ES Ko","year":"2010","unstructured":"Ko ES, Lee BH, Kim HA, Noh WC, Kim MS, Lee SA (2010) Triple-negative breast cancer: correlation between imaging and pathological findings. Eur Radiol 20(5):1111\u20131117","journal-title":"Eur Radiol"},{"issue":"3","key":"3143_CR30","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s12282-010-0223-8","volume":"18","author":"Y Kojima","year":"2011","unstructured":"Kojima Y, Tsunoda H (2011) Mammography and ultrasound features of triple-negative breast cancer. Breast Cancer 18(3):146\u2013151","journal-title":"Breast Cancer"},{"issue":"2","key":"3143_CR31","doi-asserted-by":"crossref","first-page":"458","DOI":"10.2214\/AJR.10.6096","volume":"199","author":"KM Krizmanich-Conniff","year":"2012","unstructured":"Krizmanich-Conniff KM, Paramagul C, Patterson SK et al (2012) Triple receptor-negative breast cancer: imaging and clinical characteristics. Am J Roentgenol 199(2):458\u2013464","journal-title":"Am J Roentgenol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-014-3143-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-014-3143-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-014-3143-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T14:03:27Z","timestamp":1565877807000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-014-3143-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,28]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["3143"],"URL":"https:\/\/doi.org\/10.1007\/s10549-014-3143-z","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,28]]}}}